196 related articles for article (PubMed ID: 34606057)
1. Head-to-head comparison of FNA cytology vs. calcitonin measurement in FNA washout fluids (FNA-CT) to diagnose medullary thyroid carcinoma. A systematic review and meta-analysis.
Trimboli P; Giannelli J; Marques B; Piccardo A; Crescenzi A; Deandrea M
Endocrine; 2022 Jan; 75(1):33-39. PubMed ID: 34606057
[TBL] [Abstract][Full Text] [Related]
2. Use of fine-needle aspirate calcitonin to detect medullary thyroid carcinoma: A systematic review.
Trimboli P; Guidobaldi L; Bongiovanni M; Crescenzi A; Alevizaki M; Giovanella L
Diagn Cytopathol; 2016 Jan; 44(1):45-51. PubMed ID: 26481456
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin levels in washout samples vs. cytology in the detection of malignant lymph node metastasis in recurrent medullary thyroid cancer.
Gökçay Canpolat A; Şahin M; Ceyhan K; Sak S; Demir Ö; Emral R; Erdoğan MF; Güllü S; Çorapçıoğlu D
Turk J Med Sci; 2021 Dec; 51(6):3061-3066. PubMed ID: 34519193
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study.
Trimboli P; Cremonini N; Ceriani L; Saggiorato E; Guidobaldi L; Romanelli F; Ventura C; Laurenti O; Messuti I; Solaroli E; Madaio R; Bongiovanni M; Orlandi F; Crescenzi A; Valabrega S; Giovanella L
Clin Endocrinol (Oxf); 2014 Jan; 80(1):135-40. PubMed ID: 23627255
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value and cost-effectiveness of FNA-CT versus FNAC for medullary thyroid carcinoma.
Wang M; Chen H; Wang Y; Lei J; Li Z
Clin Endocrinol (Oxf); 2023 May; 98(5):709-718. PubMed ID: 36394172
[TBL] [Abstract][Full Text] [Related]
6. Serum calcitonin negative mixed medullary-follicular carcinoma initially diagnosed as medullary thyroid carcinoma by fine-needle aspiration cytology: A case report and review of the literatures.
Liu Y; Yuan L; Yang D; Jin Y
Diagn Cytopathol; 2018 Aug; 46(8):690-693. PubMed ID: 29524315
[TBL] [Abstract][Full Text] [Related]
7. Optimizing Diagnostic Accuracy of Fine Needle Aspiration Biopsy Calcitonin Measurements in Detecting Medullary Thyroid Carcinoma.
Cavallo AC; Pitoia F; Roberti J; Brenzoni P; Lencioni M; Jaroslavsky MJ; Spengler E; Voogd A; Firpo C; Saco P; Piñero F; Negueruela M
Thyroid; 2024 Feb; 34(2):186-196. PubMed ID: 38047535
[No Abstract] [Full Text] [Related]
8. Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis.
Trimboli P; Treglia G; Guidobaldi L; Romanelli F; Nigri G; Valabrega S; Sadeghi R; Crescenzi A; Faquin WC; Bongiovanni M; Giovanella L
Clin Endocrinol (Oxf); 2015 Feb; 82(2):280-5. PubMed ID: 25047365
[TBL] [Abstract][Full Text] [Related]
9. Lymph Node Metastases of Medullary Thyroid Cancer: Role of Calcitonin in the Washout Fluid of Fine-Needle Aspiration.
Marques B; Cunha N; Martins RG; Elvas AR; Couto J; Santos J; Martins T; Moniz AP; Ilhéu O; Valido F; Rodrigues F
Int J Endocrinol; 2020; 2020():9267972. PubMed ID: 32322267
[TBL] [Abstract][Full Text] [Related]
10. An old friend, a new insight: Calcitonin measurement in serum and aspiration needle washout fluids significantly increases the early and accurate detection of medullary thyroid cancer.
Ogmen BE; Ince N; Aksoy Altınboga A; Akdogan L; Polat SB; Genc B; Menekse E; Aydin C; Topaloglu O; Ersoy R; Cakir B
Cancer Cytopathol; 2024 Mar; 132(3):161-168. PubMed ID: 37950525
[TBL] [Abstract][Full Text] [Related]
11. Performing Calcitonin Immunocytochemistry on an Additional ThinPrep Slide in Fine-Needle Aspiration Diagnosis of Medullary Thyroid Carcinoma.
Ahmed M; Abi-Raad R; Fu L; Holt EH; Adeniran AJ; Cai G
Am J Clin Pathol; 2022 Mar; 157(3):426-433. PubMed ID: 34596209
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma.
Boi F; Maurelli I; Pinna G; Atzeni F; Piga M; Lai ML; Mariotti S
J Clin Endocrinol Metab; 2007 Jun; 92(6):2115-8. PubMed ID: 17405835
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of Serum Calcitonin in Patients Without a Suspicious History of Medullary Thyroid Carcinoma and with Thyroid Nodules Without an Indication for Fine-Needle Aspiration or with Benign Cytology.
Rosario PW; Calsolari MR
Horm Metab Res; 2016 Jun; 48(6):372-276. PubMed ID: 27203410
[TBL] [Abstract][Full Text] [Related]
14. Cytology versus calcitonin assay in fine-needle aspiration biopsy wash-out fluid (FNAB-CT) in diagnosis of medullary thyroid microcarcinoma.
Liu Z; Zhou W; Han R; Zhou W; Zhang J; Li H; Wan Z; Jin Y; Shen L; Zhou Y; Wang S; Chen X; Ye L
Endocrine; 2021 Nov; 74(2):340-348. PubMed ID: 34028648
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic tests for medullary thyroid carcinoma: an umbrella review.
Trimboli P; Mian C; Piccardo A; Treglia G
Endocrine; 2023 Aug; 81(2):183-193. PubMed ID: 36877452
[TBL] [Abstract][Full Text] [Related]
16. Measuring calcitonin in washout of the needle in patients undergoing fine needle aspiration with suspicious medullary thyroid cancer.
Trimboli P; Rossi F; Baldelli R; Laurenti O; Nigri G; Ventura C; Appetecchia M; Attanasio D; Romanelli F; Guidobaldi L; Guarino M; Crescenzi A; Valabrega S
Diagn Cytopathol; 2012 May; 40(5):394-8. PubMed ID: 21563324
[TBL] [Abstract][Full Text] [Related]
17. [Calcitonin measurement in fine-needle washout fluids in detecting medullary thyroid cancer].
Zuraeva ZT; Nikankina LV; Kolesnikova GS; Abdulhabirova FM; Beltsevich DG; Malysheva NM; Mikheenkov AA
Probl Endokrinol (Mosk); 2023 Jun; 69(3):9-15. PubMed ID: 37448242
[TBL] [Abstract][Full Text] [Related]
18. An Unusual Case of Medullary Thyroid Carcinoma and A Revision of Current Literature.
Cipri C; Vescini F; Torresan F; Pennelli G; Pelizzo MR; Triggiani V; Guastamacchia E; Grimaldi F
Endocr Metab Immune Disord Drug Targets; 2019; 19(2):226-229. PubMed ID: 30574858
[TBL] [Abstract][Full Text] [Related]
19. Serum markers measured in FNA fluids of medullary thyroid carcinoma occurring as a cyst.
Trimboli P; Guidobaldi L; Locuratolo N; Piro FR; Giordano M; Giovanella L
Int J Biol Markers; 2016 May; 31(2):e224-7. PubMed ID: 27032378
[TBL] [Abstract][Full Text] [Related]
20. ProGRP AS A NOVEL BIOMARKER FOR THE DIFFERENTIAL DIAGNOSIS OF MEDULLARY THYROID CARCINOMA IN PATIENTS WITH THYROID NODULES.
Liang X; Zhu J; Cai M; Dai Z; Fang L; Chen H; Yu L; Lin Y; Lin E; Wu G
Endocr Pract; 2020 May; 26(5):514-522. PubMed ID: 32045291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
